Search

1 Jun 2023: Share:. The innovation aims to tackle the financial and environmental costs that arise when home-owners need to adapt their homes to changing life circumstances, such as new arrivals or changing

2 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. Data Protection Policy. This Data Protection Policy was approved by the Cambridge Enterprise Senior Management Team on 16 May 2018 and last reviewed on 21 May 2020. Cambridge Enterprise

22 Feb 2023: and Europe, as well as its expansion into new markets, such as Scandinavia. ... that we—a UK-based life science manufacturing company—have received from both our existing and new investors.

15 Mar 2023: We founded Nyobolt following the discovery of new anode technologies containing tungsten with remarkable, fast-charging capability to bring these properties to the market in applications touching all aspects of daily ... This partnership is also going to

26 Jan 2023: University of Cambridge technology spin-out Zetta Genomics has raised £2.5 million in new seed funding. ... The UK has led the world with its new Genomics Medicine Service, making testing routine within the publicly funded NHS.

27 Jul 2023: Recognising the need to understand risk and to build resilience globally, Habitat for Humanity have been working with the University of Cambridge...

22 Feb 2023: Cambridge Enterprise joins in a £1 million investment in Carbon Re, a UK climate tech start-up using AI to cut CO₂ emissions in the cement industry.

24 May 2023: Their activities support artists’ talent development and place-making to deliver dynamic, imaginative new experiences for the public. ... Stay informed about the Creative Cambridge event and news focused on the creative industries and opportunities for

1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – events participants. How we use your personal information – events participants. This policy explains what personal information we gather

22 Feb 2023: With exponential growth in the study of stem cells—for disease modelling, drug screening, precision medicine and development of new therapeutics—the need for high quality reagents for fine control of

17 Nov 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – Founders at the University of Cambridge. How we use your personal information – Founders at the University of Cambridge. This policy is

22 Feb 2023: Paragraf, the graphene technology development company, a spin-out from the University of Cambridge, has closed a £16.2m series A round. Draper Esprit joined...

22 Feb 2023: University spin-out Echion Technologies scored a second-place win in the Energy and Environment category of the RSC's Emerging Technologies Competition.

22 Feb 2023: Share:. ApcinteX, Morphogen-IX, Z Factor join seven other privately held biotech companies in a new type of pharmaceutical R&D model. ... With this first-of-its-kind model, we are bringing together programs with robust genetic and biological validation

27 Jun 2023: 23 June 2023. New type of computer memory could greatly reduce energy use and improve performance. ... One potential solution to the problem of inefficient computer memory is a new type of technology known as resistive switching memory.

22 Feb 2023: We are working hard to find new ways in which to tackle this difficult disease, which is especially highlighted during this World Parkinson Awareness week, for patients and their families”.

20 Nov 2023: forward to working with Gerard and the team to make this new initiative a success. ... Founders at the University of Cambridge is a brilliant initiative that will enable a new cohort of deep tech and knowledge-intensive startups to thrive.

22 Feb 2023: Cytora, a pioneer in event detection, whose technology is deployed globally, has raised a second round of investment led by Cambridge Enterprise...

22 Feb 2023: This pioneering new joint venture will support the translation of ground-breaking academic science from within these universities into innovative new medicines for a broad range of diseases. ... The Apollo Therapeutics Fund should benefit the UK economy

20 Apr 2023: Share:. New investment comes from existing VC backers as the company configures for Series A funding. ... In just 13 months, the company has attracted global leadership talent – including CEO Mark Bailey, grown headcount from five to 30, opened its

5 Oct 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 October 2023. Universities of Lincoln and Cambridge work with Ceres Agri-Tech to win £4.9m EPSRC award for global agri-tech innovation hub. Share:. Funding to boost drive to make

26 Oct 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. ISOLDE: Building High Quality Macromolecular Models into Low Resolution Experimental Maps. ISOLDE is a ChimeraX plugin (installable via its built-in Tool Shed) designed to ease the task

10 Aug 2023: Co-founded by Dr Tongtong Zhu (CEO), Dr Yingjun Liu (CTO) and Professor Rachel Oliver (CSO), Porotech had hit upon and developed a new class of porous gallium nitride (GaN) semiconductor ... This latest funding will accelerate our work to ensure that

22 Feb 2023: 19 September 2019. New agreement with Cambridge spin-out PredictImmune lets SLE join pipeline. ... The expanded agreement will allow PredictImmune to evolve its product development pipeline, accelerating its commercial offering into this new therapeutic

26 Oct 2023: MiniCPC led by Molly Haugen (Department of Engineering). New Battery Co. led by Ismail Sami (Department of Materials Science and Metallurgy).

1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – University of Cambridge staff and students. How we use your personal information – University of Cambridge staff and students. This policy

1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – subscribers to digital newsletters and updates. How we use your personal information – subscribers to digital newsletters and updates. This

22 Feb 2023: We are pleased to announce that Cambridge Enterprise, the University of Cambridge Enterprise Fund IV, managed by Parkwalk, and Cambridge Innovation Capital...

22 Feb 2023: The continued support from our seed investors and interest from new investors demonstrates the robustness of our technology and underlines the rapid progress Aqdot is making. ... Tim Wright, CEO at Aqdot, said “the continued support from our seed

22 Feb 2023: The latest technologies stemming from research at Oxford and Cambridge were presented to investors at an event held at the Royal Society of Chemistry.

22 Feb 2023: Stem cells are revolutionising medicine by enabling new approaches for disease modelling, precision medicine and development of new therapeutics. ... The need for quality and reproducibility in stem cell biology and exciting new areas such as organoids

23 Feb 2023: One third of this year’s consultancy projects were from new academic consultants. ... Cambridge Enterprise also invests intellectual property and cash to create new companies and ventures based on Cambridge research.

23 Feb 2023: Share:. The Discovery Fund recently made its second investment in a new University spin-out that is developing water droplets that serve as ‘miniature test tubes’. ... Dr Geraldine Rodgers. Dr Frank Craig has been recruited as CEO, and the

22 Feb 2023: sectors, where they will be used to model a range of diseases and accelerate the development of new treatments. ... This funding is helping develop new therapies and treatments for conditions which affect millions worldwide, including liver disease,

5 Jul 2023: Apollo is now advancing into clinical development as well as identifying new programmes. ... profi le. Evidence included scientifi c papers, government reports, and local news articles.

22 Feb 2023: technology. Proteins and their behaviour are crucial to understanding how diseases develop, identifying the way that drugs interact with their targets, and developing new methods for matching the right treatment to ... Joining the round as new investors

22 Feb 2023: Trials of the kits conducted at leading research centres around the world have already begun to yield new insights into genome function and highlighted the advantages of TrueMethyl relative to traditional ... Consequently, this pioneering analytical

3 Jul 2023: What could be truly new at an 800-year-old university? More than you could ever imagine. ... Investments totalling £10.85 million were approved in 21 businesses: 10 new and 11 follow-on.

22 Feb 2023: The new funding will help drive DefiniGEN to profitability and enable the Company to achieve the following:. ... We are delighted to have raised the funds that will allow us to deliver new market-leading products to our customers and assist them in

22 Feb 2023: The Postdoc Business Plan Competition was won by Accelerated Materials which helps businesses create innovative products with nanomaterials

22 Feb 2023: We are delighted to announce that Cambridge Enterprise and the Parkwalk Opportunities Fund and have completed an investment in PredictImmune Limited, a...

23 Feb 2023: Drug discovery company Storm Therapeutics announces the appointment of Keith Blundy as CEO and Tim Edwards as Chairman.

22 Feb 2023: Nyobolt—a cutting-edge battery company that is defining a new category of ultra-high power technology—has secured $10 million in Series A funding. ... The funding will enable Nyobolt to expand globally, building new facilities and growing its

22 Feb 2023: Jonathan Milner and other local angels have formed a syndicate with the Enterprise Fund to support this exciting new venture. ... The scheme allows individuals to invest in new companies while benefitting from generous tax incentives.

22 Feb 2023: 12 December 2013. Definigen raises £1.3m in funding. Share:. Cambridge spin-out Definigen has completed a new funding round worth £1.3 million, led by Cambridge Enterprise. ... Definigen will use the funding to accelerate production and introduce new

23 Feb 2023: Sphere Fluidics’ technology enables the study of the mechanism of cancer cell resistance to chemotherapy, the generation of new enzymes and identification of novel microbial strains.

23 Feb 2023: months are just some of the technologies being developed by new companies based on Cambridge research, with funding support from the University seed funds. ... The companies receiving either new or follow-on support included Aqdot, CamSemi, DefiniGEN,

22 Feb 2023: He added: “We would also like to welcome our new CEO, Dr Fedja Bobanovic, who has an exceptional track record of generating growth in life sciences businesses.“. ... Somu Subramanian, new board member and founding partner of New Science Ventures,

22 Feb 2023: 17 March 2020. DIOSynVax works towards vaccine against COVID-19. Share:. It is hard now to conceive that two months ago few people had heard of the new coronavirus. ... In the past few years, Heeney has won significant funding and investment from the

23 Nov 2023: to share best practice and open up new avenues of agri-tech research.